Looking at the full scope of PAD: Cases, techniques, and economic considerations for complex disease.

Table of Contents

Current Challenges for the Modern Management of PAD
An overview of contemporary and emerging practices in peripheral artery disease.
By Fanny S. Alie-Cusson, MD, and Jean M. Panneton, MD, FRCSC, FACS

Case Report: Treating a Long Chronic Total Occlusion in a Patient With CLI
A personalized treatment approach to a challenging case.
By Erik Weekman, BS; Vinayak Subramanian, BS; Ivy Smith, BS; and George L. Adams, MD, MHS, FACC, FSCAI

Treatment Challenges for Femoropopliteal Lesions
Discussion on managing complex peripheral artery disease, particularly in the femoropopliteal region, and a relevant case study to highlight specific challenges.
With M. Casey Becker, MD, FACC, FSCAI, FSVM

Case Report: Aortoiliac Occlusion in a Patient With Severe Claudication
Management with covered balloon-expandable stents provides another option for complex disease.
By Ehrin J. Armstrong, MD, MSc

Best Practices for Lower Extremity Bypass
Surgical and endoluminal treatment considerations for femoropopliteal lesions.
With Russell H. Samson, MD, FACS, RVT, DFSVS

Stenting Lesions in Distal Anatomy
Perspective on a modern-day treatment algorithm.
With Martin Werner, MD

A Physician Perspective on Collaborating With Your Hospital’s Value Analysis Committee
Speaking with a physician leader at Atrium Health’s Sanger Heart and Vascular Institute about advocating for physician device preferences and effectively communicating with key stakeholders.
With Frank R. Arko III, MD

GORE VIABAHN VBX Balloon Expandable Endoprosthesis
Designed to expand to every demand, the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes through flexibility, strength and accuracy to treat aortoiliac occlusive disease.
GORE VIABAHN Endoprosthesis

Proven across a broad range of complex cases, the versatility of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface†,‡ enables you to deliver high patency and durable outcomes to minimize interventions for your patients.

*As used by Gore, Heparin Bioactive Surface refers to Gore’s proprietary CBAS® Heparin Surface.


Endovascular Today February 2019 Supplement

Endovascular Today February 2019 Supplement
Looking at the Full Scope of PAD